UCSF Adult Inpatient Susceptibility Data (Gram-Negatives)1
R-testing not applicable to organism and should be considered resistant, CFPM-cefepime, CIP-ciprofloxacin, CTAZ-ceftazidime, CTRX-ceftriaxone, ERTA-ertapenem, IMI-imipenem, P/T-piperacillin-tazobactam, TOB-tobramycin
Total isolates include floor isolates and ICU isolates from Parnassus, MB Adult, and MZ
Reported as % susceptible, tested from all sites except as indicated
Organism |
Total Isolates |
CFPM |
CIP |
CTAZ |
CTRX |
ERTA |
IMI4 |
P/T |
TOB |
|---|---|---|---|---|---|---|---|---|---|
|
Weighted average of all Gram-negative organisms |
2030 |
87 [91]2 |
75 |
85 |
63 (78)3 |
78 (97)3 |
955 |
88 |
91 |
|
Citrobacter freundii |
55 |
96 [100]2 |
69 |
R |
R |
98 |
100 |
R |
90 |
|
Enterobacter cloacae |
127 |
88 [98]2 |
94 |
R |
R |
89 |
96 |
R |
94 |
|
Escherichia coli |
793 |
84 [88]2 |
64 |
86 |
77 |
98 |
99 |
93 |
88 |
|
Klebsiella aerogenes |
46 |
95 [95]2 |
89 |
R |
R |
100 |
86 |
R |
97 |
|
Klebsiella oxytoca |
103 |
94 [97]2 |
92 |
93 |
86 |
97 |
99 |
85 |
93 |
|
Klebsiella pneumoniae |
279 |
81 [87]2 |
75 |
81 |
77 |
97 |
98 |
89 |
86 |
|
Proteus mirabilis |
163 |
95 [98]2 |
75 |
95 |
92 |
100 |
1006 |
99 |
87 |
|
Pseudomonas aeruginosa |
398 |
89 |
82 |
87 |
R |
R |
85 |
80 |
97 |
|
Serratia marcescens |
66 |
100 [100]2 |
95 |
100 |
98 |
100 |
98 |
100 |
96 |
1Adult inpatient susceptibilities include data from 4/1/22-3/31/23; 2Brackets reflect % susceptible including susceptible dose-dependent isolates for Enterobacterales (excludes Pseudomonas); 3Parentheses excludes Pseudomonas isolates; 4Predicts meropenem susceptibility; 5Weighted average excludes 163 Proteus mirabilis isolates tested against imipenem; 6Reflects meropenem non-urine isolates (65 total isolates)